Medical Design Technology -
7 Apr 2017 15:54
News In this randomized, non-blinded study, a multi-institutional team found that 69 percent of the 151 patients who received Abbott's Heartmate 3 ... Contributed Author: University of Chicago Medical Center Topics: Cardiovascular
Share this Article